PF-Atlas › Clinical Trials › NCT03251911
VX-770 for the Treatment of Chronic Bronchitis
Ivacaftor · Phase 4
Registry ID
NCT03251911
Phase
Phase 4
Status
Withdrawn
Drug / intervention
Ivacaftor (VX-770)
Sponsor
University of Alabama at Birmingham
Start
2020-01-01
About this trial
Ivacaftor is evaluated in NCT03251911, a Phase 4 idiopathic pulmonary fibrosis study sponsored by University of Alabama at Birmingham. Current status: Withdrawn.
Explore related
Related trials
Medical disclaimer. This page summarizes public trial data for NCT03251911 for information only. It is not medical advice, an endorsement, or an offer to enroll. Confirm details on ClinicalTrials.gov and with a qualified physician.